Estimation and validation of a multiattribute model of alzheimer disease progression

Medical Decision Making

Volumn 30, Issue 6, 2010, Pages 625-638

  Stallard, Eric ^a   Kinosian, Bruce ^b,c   Zbrozek, Arthur S ^d   Yashin, Anatoliy I ^a   Glick, Henry A ^b   Stern, Yaakov ^e  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d PFIZER INC   (United States)

^e New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

clinical assessment; outcomes; staging of dementia

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BAYES THEOREM; DECISION MAKING; DECISION SUPPORT SYSTEM; DISEASE COURSE; ECONOMICS; FEMALE; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MALE; MEDICAID; MEDICARE; PATHOLOGY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PSYCHOMETRY; SEX DIFFERENCE; STATISTICAL MODEL; UNITED STATES; VALIDATION STUDY;

AGED; ALZHEIMER DISEASE; BAYES THEOREM; BIOLOGICAL MARKERS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; MEDICAID; MEDICARE; MODELS, ECONOMIC; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; PSYCHOMETRICS; SEX FACTORS; UNITED STATES;

EID: 78650828551     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10363479     Document Type: Article

References (36)

1. Sonnenberg FA, Beck JR Markov models in medical decision making: a practical guide. Med Decis Making. 1993 ; 13 (4). 322-38.
2. Neumann PJ, Hermann RC, Kuntz KM, et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology. 1999 ; 52 (6). 1138-46.
3. Neumann PJ, Araki SS, Arcelus A., et al. Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD. Neurology. 2001 ; 57 (6). 957-64.
4. Kuntz KM, Goldie SJ Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity bias. Med Decis Making. 2002 ; 22 (3). 218-27.
5. Stern Y., Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. JAMA. 1997 ; 277 (10). 806-12.
6. Caro JJ, Getsios D., Migliaccio-Walle K., Raggio G., Ward A. Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care. Neurology. 2001 ; 57 (6). 964-71.
7. Getsios D., Migliaccio-Walle K., Caro JJ NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? Pharmacoeconomics. 2007 ; 25 (12). 997-1006.
8. Reisberg B., Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982 ; 139 (9). 1136-9.
9. Hughes CP, Berg L., Danziger WL, Coben LA, Martin RL A new clinical scale for the staging of dementia. Br J Psychiatry. 1982 ; 140: 566-72.
10. Dooneief G., Marder K., Tang MX, Stern Y. The Clinical Dementia Rating scale: community-based validation of "profound" and "terminal" stages. Neurology. 1996 ; 46: 1746-9.
11. Eisdorfer C., Cohen D., Paveza GJ, et al. An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease. Am J Psychiatry. 1992 ; 149 (2). 190-4.
12. Stern Y., Liu X., Albert M., et al. Application of a growth curve approach to modeling the progression of Alzheimer's disease. J Gerontol Med Sci. 1996 ; 51A (4). M179-84.
13. Green C. Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. Pharmacoeconomics. 2007 ; 25 (9). 735-50.
14. Alzheimer's Association. Markers in blood and spinal fluid, and a new imaging agent, show promise for early detection of Alzheimer's. ICAD 2008 Press Release. Chicago, IL, 29 July 2008.
15. Kinosian BP, Stallard E., Lee JH, Woodbury MA, Zbrozek AS, Glick HA Predicting 10-year care requirements for older people with suspected Alzheimer's disease. J Am Geriatr Soc. 2000 ; 48 (6). 631-8.
16. Stallard E. Trajectories of morbidity, disability, and mortality among the U.S. elderly population: evidence from the 1984-1999 NLTCS. North American Actuarial Journal. 2007 ; 11 (3). 16-53.
17. Woodbury MA, Clive J. Clinical pure types as a fuzzy partition. J Cybernet. 1974 ; 4 (3). 111-21.
18. Fillenbaum GG, Woodbury MA Typology of Alzheimer's disease: findings from CERAD data. Aging Mental Health. 1998 ; 2 (2). 105-27.
19. Erosheva EA Comparing latent structures of the grade of membership, Rasch, and latent class models. Psychometrika. 2005 ; 70 (4). 619-28.
20. Ramsay JO A geometrical approach to item response theory. Behaviormetrika. 1996 ; 23 (1). 3-16.
21. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978 ; 6 (2). 461-4.
22. Raftery A. Bayesian model selection in social research. Sociol Methodol. 1995 ; 25: 111-63.
23. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Second International Symposium on Information Theory. Budapest (Hungary): Akademiai Kiado; 1973 ; 267-81.
24. Bozdogan H. Model selection and Akaike's information criterion (AIC): the general theory and its analytical extensions. Psychometrika. 1987 ; 52 (3). 345-70.
25. Stern Y., Folstein M., Albert M., et al. Multicenter study of predictors of disease course in Alzheimer disease (the "Predictors Study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord. 1993 ; 7 (1). 3-21.
26. Zhu CW, Scarmeas N., Torgan R., et al. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology. 2006 ; 66 (7). 1021-8.
27. Stern Y., Sano M., Paulson J., Mayeux R. Modified Mini-Mental State Examination: validity and reliability. Neurology. 1987 ; 37 (suppl 1). 179.
28. Blessed G., Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 ; 114 (512). 797-811.
29. Stern Y., Albert SM, Sano M., et al. Assessing patient dependence in Alzheimer's disease. J Gerontol. 1994 ; 49 (5). M216-22.
30. Sarazin M., Stern Y., Berr C., et al. Neuropsychological predictors of dependency in patients with Alzheimer's disease. Neurology. 2005 ; 64 (6). 1027-31.
31. Grabowski DC, Feng Z., Intrator O., Mor V. Recent trends in state nursing home payment policies. Health Affairs Suppl Web Exclusives. 2004 ; W4: 363-73.
32. Holtzer R., Tang MX, Devanand DP, et al. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. J Am Geriatr Soc. 2003 ; 51 (7). 953-60.
33. Scarmeas N., Brandt J, Albert, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005 ; 62 (10). 1601-8.
34. Alzheimer's Association. 2008 Alzheimer's Disease Facts and Figures. Washington (DC): Alzheimer's Association, 2008. p 27.
35. Centers for Medicare & Medicaid Services. Medicaid at-a-Glance 2005. Baltimore (MD): Centers for Medicare & Medicaid Services ; 2005. Pub No. CMS- 11024-05.
36. Wachter KW Grade of membership models in low dimensions. Statistical Papers. 1999 ; 40 (4). 439-57.